Replies to post #19095 on NorthWest Biotherapeutics Inc (NWBO)

[Rkmatters]

Forgive me, but wouldn't these companies be shareholder's too? If the payment situation for some 90,000 patients isn't going to be good for NWBT, one would expect it would eventually hurt the stock price? If it hurts the stock price, Toucan and Cognate have more to lose, than they would on the payout for services rendered, at least before the scale up point anyway. This leads me to conclude, Linda will be thinking in the best interest of us shareholders, as they will have the most to gain as well. But, I thought that she would anyway, well before applying rational reasoning. :)